Role of Endoscopic Third Ventriculostomy Imanagement of Hydrocephalus in Pediatric Age Group; Clinical and Surgical Outcome

ConditionHydrocephalus
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-18
SponsorSohag University

About this trial

Endoscopic third ventriculostomy in cases of hydrocephalus provide less invasive and safe technique than ventriculoperitoneal Shunt also decrease complications of ventriculoperitoneal Shunt

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

cases hydrocephalus diagnosed by CT or MRI.in pediatric age group up to 18 years

Both sex (males and females) will be included.

Disqualifiers

cases with hydrocephalus associated with csf infection or hemorrhage

Previously operated VP shunt or ETV .

Mult cystic hydrocephalus

Trial design

Design model

Single group

Treatments tested in this trial

  • Fenestration of the floor of the third ventricle

    Procedure/Surgery

    Endoscopic third ventriculostomy of the third ventricle of the brain

  • Endoscopic third ventriculostomy of the brain third ventricle

    Procedure/Surgery

    Surgeons insert a rigid endoscope through a small burr hole in the skull into the ventricular system. They use a catheter or laser to puncture a tiny, precise opening in the floor of the third ventricle

  • Endoscopic third ventriculostomy

    Procedure/Surgery

    Surgeons insert a rigid endoscope through a small burr hole in the skull into the ventricular system. They use a catheter or laser to puncture a tiny, precise opening in the floor of the third ventricle

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Hydrocephalus in pediatric age groupOther 3 interventions

Trial outcomes

Primary outcomes

1

Changes in manifestation according to ETVSS endoscopic third ventriculostomy success score with assement of level of consciousness degree of papiledema and severity of headache

ETVSS ETV success score is predictive tool used to estimate ETV success based on factors like age etiology previous shunt other pathologies The score is expressed as a number from 0 to 90 with assement of level of consciousness degree of papiledema and severity of headache Score 70 indicate an estimated 70 % chance of success

Time frame
6 month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: